A detailed history of Jackson Square Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jackson Square Partners, LLC holds 4,752 shares of LLY stock, worth $3.55 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
4,752
Previous 6,537 27.31%
Holding current value
$3.55 Million
Previous $5.92 Million 28.88%
% of portfolio
0.37%
Previous 0.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $1.38 Million - $1.71 Million
-1,785 Reduced 27.31%
4,752 $4.21 Million
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $566,123 - $709,960
-781 Reduced 10.67%
6,537 $5.92 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $42,046 - $56,251
-71 Reduced 0.96%
7,318 $5.69 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $3.88 Million - $4.57 Million
7,389 New
7,389 $4.31 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jackson Square Partners, LLC Portfolio

Follow Jackson Square Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Partners, LLC with notifications on news.